Literature DB >> 24633728

Myeloid-derived suppressor cells in pancreatic cancer: more than a hidden barrier for antitumour immunity?

Tim F Greten.   

Abstract

Entities:  

Keywords:  Pancreatic Cancer

Mesh：

Substances：

Year:  2014        PMID： 24633728     DOI： 10.1136/gutjnl-2014-306790

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer.

Authors:  Li Xiao; Ulrike Erb; Kun Zhao; Thilo Hackert; Margot Zöller
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

2.  Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer.

Authors:  Eveline E Vietsch; Casper Hj van Eijck; Anton Wellstein
Journal:  Pancreat Disord Ther       Date:  2015-06

3.  Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF1-dependent pathway.

Authors:  Ke Chen; Weikun Qian; Jie Li; Zhengdong Jiang; Liang Cheng; Bin Yan; Junyu Cao; Liankang Sun; Cancan Zhou; Meng Lei; Wanxing Duan; Jiguang Ma; Qingyong Ma; Zhenhua Ma
Journal:  Mol Oncol       Date:  2017-08-29       Impact factor: 6.603

Review 4.  Immunotherapy for pancreatic cancer.

Authors:  Jai Hoon Yoon; Ye-Ji Jung; Sung-Hoon Moon
Journal:  World J Clin Cases       Date:  2021-05-06       Impact factor: 1.337

5.  Peripheral blood monocytes predict clinical prognosis and support tumor invasiveness through NF-κB-dependent upregulation of Snail in pancreatic cancer.

Authors:  Shaojie Chen; Feifei Huang; Chong He; Jiajia Li; Shangxiang Chen; Yaqing Li; Yinting Chen; Guoda Lian; Kaihong Huang
Journal:  Transl Cancer Res       Date:  2021-11       Impact factor: 1.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.